Capital International Investors 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-09 2:31 pm Sale | 2022-12-12 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Capital International Investors | 1,711,517 2.400% | -3,917,936 (-69.60%) | Filing |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Capital International Investors | 5,629,453 8.300% | -1,270,040 (-18.41%) | Filing |
| 2021-02-16 4:04 pm Purchase | 2021-02-16 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Capital International Investors | 6,899,493 10.500% | 304,831 (+4.62%) | Filing |